HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intracavernosal injection of vascular endothelial growth factor induces nitric oxide synthase isoforms.

AbstractOBJECTIVE:
To identify genes that are affected by vascular endothelial growth factor (VEGF), as an intracavernosal injection with VEGF improved the recovery of erectile function in a rat model of arteriogenic impotence, specifically examining the three nitric oxide synthase (NOS) genes, nNOS, eNOS, and iNOS.
MATERIALS AND METHODS:
Male rats had their pudendal arteries ligated or underwent a sham operation. They were then treated by an intracavernosal injection with 4 microg of VEGF in phosphate-buffered saline (PBS) or PBS alone. At 6 and 24 h after treatment electrostimulation was applied to the cavernosal nerve and the intracorporal pressure measured. The erectile tissue was then harvested for RNA isolation and cryo-sectioning. The isolated RNA was used for microarray and reverse transcription-polymerase chain reaction (RT-PCR) analyses, and the tissue sections for immunohistochemical analysis.
RESULTS:
Microarray analysis detected nNOS, eNOS and iNOS at very low expression levels in PBS-treated rats; expression levels were higher for eNOS and iNOS in all VEGF-treated rats. These results were further confirmed by RT-PCR analysis. Immunohistochemical analysis identified the cavernosal endothelium and smooth muscle as the tissue types where eNOS and iNOS were up-regulated, respectively.
CONCLUSIONS:
This is the first report of the induction of both eNOS and iNOS in the penis after intracavernosal VEGF. These events may help support a significant recovery of erectile function after interrupting the blood supply to the penis.
AuthorsC-S Lin, H-C Ho, K-C Chen, G Lin, L Nunes, T F Lue
JournalBJU international (BJU Int) Vol. 89 Issue 9 Pg. 955-60 (Jun 2002) ISSN: 1464-4096 [Print] England
PMID12010247 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Carrier Proteins
  • Endothelial Growth Factors
  • RNA, Messenger
  • Vascular Endothelial Growth Factor A
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
  • NOSIP protein, human
  • Ubiquitin-Protein Ligases
Topics
  • Animals
  • Carrier Proteins (genetics, metabolism)
  • Endothelial Growth Factors (administration & dosage, pharmacology)
  • Immunohistochemistry (methods)
  • Impotence, Vasculogenic (enzymology)
  • Injections
  • Male
  • Nitric Oxide Synthase (genetics, metabolism)
  • Nitric Oxide Synthase Type II
  • Penis (drug effects)
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Reverse Transcriptase Polymerase Chain Reaction
  • Ubiquitin-Protein Ligases
  • Vascular Endothelial Growth Factor A

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: